We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Microplastics as a Cross-Disease Driving Risk Factor in Lung Pathogenesis: An Integrative Study Combining In Silico Analysis and Experimental Validation Using Polystyrene Nanoplastics
Original title: Microplastics as a Cross‐Disease Driving Risk Factor in Lung Pathogenesis: An Integrative Study Combining In Silico Analysis and Experimental Validation Using Polystyrene Nanoplastics
AI summary Read the abstract
Scientists found that tiny plastic particles (nanoplastics) may contribute to serious lung diseases like COPD, pulmonary fibrosis, and lung cancer by switching on a gene called CDK1, which causes lung cells to scar and malfunction. In lab tests on human lung cells, exposure to these plastic particles triggered fibrosis (tissue scarring), and blocking CDK1 reduced this damage—suggesting this gene could be a target for future treatments. This research adds to growing evidence that the microplastics we breathe in from air pollution may have real consequences for lung health, not just being a passive pres
Microplastics (MPs), as environmental pollutants, have garnered widespread attention. Growing evidence suggests a close association between MP exposure and lung diseases. However, the molecular mechanisms through which MP exposure influences the onset and progression of lung diseases remain unclear. This study positions MP exposure as a cross-disease driving risk factor and employs integrated computational toxicology and bioinformatics approaches to explore potential key targets underlying the impact of MP exposure on the development of lung diseases (COPD, IPF, and LUAD). Common differentially expressed genes (cDEGs) and shared common DEGs (scDEGs) associated with MP exposure and COPD, IPF, and LUAD were identified through database screening and intersection analysis. A protein-protein interaction (PPI) network was constructed using the STRING database, followed by enrichment analysis. The expression patterns and cellular localization of key targets among the shared common differentially expressed genes were validated using single-cell datasets of COPD, IPF, and LUAD. Finally, experimental validation was conducted based on the cell types identified through analysis. MP exposure may influence the occurrence and progression of COPD, IPF, and LUAD through mechanisms involving the cell cycle, mitosis, and DNA repair. Potential key targets identified include CDK1, BRCA1, and CCND1. Validation via database and single-cell analyses suggests that MP exposure may increase the risk of COPD, IPF, and LUAD by upregulating CDK1 expression in pulmonary fibroblasts. Experimental validation in human pulmonary fibroblasts demonstrated that PS-NPs significantly upregulated CDK1 mRNA and protein levels in a dose-dependent manner. CDK1 inhibition experiments confirmed that PS-NP exposure promotes fibrosis in human pulmonary fibroblasts by upregulating CDK1. This study defines MP exposure as a cross-disease driving risk factor and identifies CDK1 as a potential key target mediating the development of MPs-driven lung diseases. This finding offers a new perspective for understanding MPs-related lung diseases and establishes a novel paradigm for exploring the intrinsic connections between pollutant exposure and disease pathogenesis.
More Papers Like This
A particle of concern: explored and proposed underlying mechanisms of microplastic-induced lung damage and pulmonary fibrosis
AI summary Read the abstract
This paper explores how inhaled microplastics may cause lung damage and scarring (pulmonary fibrosis) through several biological pathways. The research identifies signaling pathways that could be targeted for future treatments to reduce microplastic-induced lung damage. This is relevant to human health because people regularly breathe in airborne microplastic particles.
Microplastics in the Lungs: Exposure Pathways, Pulmonary Deposition, Toxicological Effects, and Carcinogenic Potential
AI summary Read the abstract
This review summarizes existing research on tiny plastic particles found in human lungs after breathing them in. Lab studies on plastic particles showed inflammation, cell damage, and genetic damage, while human data remain limited but confirm microplastics are present in lungs, linked to inflammatory and fibrotic lung conditions.
Intratracheal administration of polystyrene microplastics induces pulmonary fibrosis by activating oxidative stress and Wnt/β-catenin signaling pathway in mice
AI summary Read the abstract
Researchers administered polystyrene microplastics directly into the lungs of mice and found that the particles induced pulmonary fibrosis by triggering oxidative stress and activating the Wnt signaling pathway. The microplastics caused damage to the lung lining cells and promoted the buildup of scar tissue in lung tissue. The study provides evidence that inhaled microplastics may contribute to serious respiratory conditions by driving fibrotic changes in the lungs.
Potential toxicity of micro- and nanoplastics in primary bronchial epithelial cells of patients with chronic obstructive pulmonary disease
AI summary Read the abstract
Researchers investigated how micro- and nanoplastics affect lung cells taken from patients with chronic obstructive pulmonary disease (COPD), a condition that already impairs breathing. The study aimed to determine whether plastic particle exposure poses additional toxic risk to people whose airways are already compromised.
A single-cell perspective on polyethylene microplastic toxicity: linking fibroblast reprogramming to immune microenvironment alterations in the lung
AI summary Read the abstract
Scientists exposed rats' lungs to polyethylene microplastics (a common plastic found in air pollution) over time and used advanced cell-tracking technology to see exactly what happens inside lung tissue. They found that these plastic particles trigger immune cells to release signals that push scar-tissue-forming cells into overdrive, leading to thickened, scarred lung tissue and disrupted immune function. Since microplastics are already known to accumulate in human lungs, this research helps explain a possible mechanism behind plastic-related lung damage and points to specific molecules that could one day be targeted to prevent or treat it.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.